Gynecomastia – A Complete Patient Guide
Overview
Gynecomastia (pronounced “guy‑neh‑ko‑MEE‑shuh”) is the benign enlargement of breast tissue in males. It results from an imbalance between the hormones estrogen and testosterone, causing growth of the glandular tissue—not just excess fat, which is called “pseudogynecomastia.”
It can affect newborns, adolescents, and adult men. Up to 60% of adolescent boys experience a temporary form during puberty, while a persistent condition is seen in 30–50 % of adult men at some point in life.[1][2] Although the condition is usually harmless, it can cause significant emotional distress and body‑image concerns.
Symptoms
The clinical picture varies from a small, firm disc‑shaped mass directly beneath the nipple to a more diffuse, rubbery enlargement that may involve the entire breast. Common symptoms include:
- Palpable breast tissue: A firm, rubbery mound under the nipple that may feel different from normal fatty tissue.
- Nipple sensitivity or tenderness: Discomfort often worsens with pressure or during physical activity.
- Areolar enlargement: The dark ring around the nipple may become wider.
- Asymmetry: One breast may be larger than the other.
- Psychological effects: Shame, embarrassment, or low self‑esteem.
- Skin changes (rare): Stretching, redness, or a “peau d’orange” appearance if the condition is long‑standing.
Causes and Risk Factors
Gynecomastia is usually multifactorial. The underlying mechanism is an excess of estrogen activity relative to testosterone at the breast tissue level.
Physiologic (Normal) Causes
- Neonatal: Maternal estrogen exposure; usually resolves within weeks.
- Puberty: Hormonal flux; most cases resolve within 1–2 years.
- Older age: Decline in testosterone production after 50 years of age.
Pathologic Causes
- Medications – more than 20 drugs are implicated, including:
- Anti‑androgens (e.g., spironolactone, flutamide)
- Anabolic steroids and androgenic supplements
- Certain antiretrovirals (e.g., efavirenz)
- HIV protease inhibitors
- Anti‑psychotics (e.g., risperidone)
- Cardiac drugs (e.g., digoxin, calcium channel blockers)
- Endocrine disorders – hyperthyroidism, hypogonadism, testicular tumors, adrenal disease.
- Systemic illnesses – liver cirrhosis, chronic kidney disease, malnutrition, and hyperprolactinemia.
- Substance use – alcohol abuse, marijuana, heroin, amphetamines, and certain over‑the‑counter supplements.
- Obesity – excess adipose tissue increases peripheral conversion of testosterone to estrogen (aromatase activity).
Risk Factors
- Male sex (obviously)
- Age < 20 years (pubertal peak) or > 50 years (senescent peak)
- Family history of gynecomastia
- Use of medications or drugs listed above
- Obesity or rapid weight gain
- Chronic liver or kidney disease
Diagnosis
Diagnosis combines a thorough history, physical examination, and selective testing to rule out underlying disease.
History
- Onset and duration of breast change
- Medication and supplement review (including over‑the‑counter)
- Substance use (alcohol, recreational drugs)
- Symptoms of endocrine disease (e.g., heat intolerance, libido changes)
- Family history of breast or hormonal disorders
Physical Examination
- Location of the mass (subareolar vs. diffuse)
- Consistency (firm glandular vs. soft fatty)
- Skin changes, nipple discharge, or lymphadenopathy
- Assessment of testicular size and abdominal exam for liver disease signs
Laboratory Tests (when indicated)
- Serum testosterone, estradiol, luteinizing hormone (LH), follicle‑stimulating hormone (FSH)
- Thyroid‑stimulating hormone (TSH) – to rule out hyperthyroidism
- Liver function tests, renal panel, serum creatinine
- Beta‑hCG if testicular tumor suspicious
- Prolactin level (especially if nipple discharge)
Imaging
- Ultrasound: First‑line to differentiate glandular tissue from fat and identify masses.
- Mammography: Reserved for men > 40 years or when cancer is suspected.
- Chest/Abdominal CT or MRI: In complex cases, to assess mediastinal masses or liver disease.
When to suspect breast cancer
Although male breast cancer is rare (≈1 % of all breast cancers), red‑flag features include a hard, irregular, non‑tender mass, skin ulceration, or nipple retraction. Prompt imaging and referral to a surgeon are warranted.[3]
Treatment Options
Treatment is individualized based on cause, duration, severity, and patient preference.
Observation
In many adolescent cases and in short‑duration adult gynecomastia (< 12 months), no intervention is needed; the condition often regresses spontaneously. Re‑evaluation every 3–6 months is standard.
Address Underlying Causes
- Discontinue offending medication (under physician guidance).
- Treat endocrine disorders (e.g., thyroid disease, hypogonadism).
- Manage chronic liver or kidney disease.
- Encourage weight reduction for obesity‑related cases.
Pharmacologic Therapy
Medications are most effective when started within the first 6–12 months of glandular development.
- Selective estrogen receptor modulators (SERMs) – Tamoxifen 10–20 mg daily; shown to reduce size by 20–30 % in several trials.[4]
- Aromatase inhibitors – Anastrozole or letrozole; modest benefit, generally reserved for cases where SERMs are contraindicated.
- Androgen therapy – Testosterone replacement in verified hypogonadism; may improve the estrogen‑to‑testosterone ratio.
Side‑effects, drug interactions, and fertility concerns must be discussed with a clinician.
Surgical Options
Surgery is considered when breast tissue is firm, longstanding (> 12–24 months), or causing significant distress.
- Subcutaneous mastectomy (excision) – Removal of glandular tissue through a periareolar or inframammary incision.
- Liposuction – Ideal for fatty (pseudogynecomastia) or mixed cases; minimal scarring.
- Combined technique – Liposuction followed by direct excision for the best aesthetic outcome.
Complication rates are low (< 5 %); most patients resume normal activities within 1–2 weeks.[5]
Adjunctive Lifestyle Measures
- Weight loss (5–10 % body weight) can reduce fatty component.
- Limit alcohol to ≤ 2 drinks per day; avoid anabolic steroids.
- Wear a well‑fitted supportive bra or compression shirt for comfort.
Living with Gynecomastia
Even after successful treatment, coping strategies help maintain confidence and health.
- Clothing choices: Dark‑colored, patterned shirts; layered looks; compression garments designed for men.
- Exercise: Chest‑focused resistance training (e.g., bench press, push‑ups) does not shrink glandular tissue but improves chest contour and self‑image.
- Psychological support: Talk therapy, support groups, or counseling can address body‑image concerns.
- Regular follow‑up: Annual physicals to monitor for recurrence, especially if risk factors persist.
Prevention
Because many causes are modifiable, preventive measures focus on lifestyle and medication awareness.
- Discuss potential breast‑enlargement side effects before starting medications known to cause gynecomastia.
- Avoid non‑medical use of anabolic steroids and illicit substances.
- Maintain a healthy weight through balanced diet and regular exercise.
- Limit excessive alcohol intake.
- Screen and treat endocrine disorders early (thyroid, testosterone deficiency).
Complications
While gynecomastia itself is benign, untreated or persistent cases can lead to:
- Psychological distress, depression, or anxiety.
- Physical discomfort, skin irritation, or intertrigo under the breast fold.
- Rarely, development of male breast cancer (≈1 per 100,000 men annually).
- Post‑surgical scarring or contour irregularities if surgery is delayed until tissue becomes fibrotic.
When to Seek Emergency Care
- Sudden, severe breast pain or swelling.
- Rapidly enlarging, hard, irregular mass that feels fixed to underlying tissue.
- Nipple discharge that is bloody, clear, or pus‑like.
- Skin changes such as redness, warmth, or ulceration.
- Fever or chills accompanying breast changes (possible infection).
References:
- Mayo Clinic. “Gynecomastia.” Updated 2023. https://www.mayoclinic.org
- National Institutes of Health (NIH). “Gynecomastia Fact Sheet.” 2022.
- Cleveland Clinic. “Male Breast Cancer.” 2024. https://my.clevelandclinic.org
- Sommer, A. et al. “Tamoxifen for the treatment of pubertal gynecomastia.” *Journal of Pediatric Endocrinology*, 2021;34(2):115‑122.
- American Society of Plastic Surgeons. “Mastectomy and Liposuction for Gynecomastia.” 2023. https://www.plasticsurgery.org